Home monitoring during chemoradiation for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether monitoring your health at home during chemoradiation for esophageal cancer can improve care and outcomes. You'll measure things like temperature and symptoms, and share them with your care team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a type of esophageal cancer called adenocarcinoma, squamous cell carcinoma, or a mix of both.
- You will be getting chemoradiation (chemo plus radiation) that includes the drugs carboplatin and paclitaxel once a week, either before surgery or as your main treatment.
- You agree to take part and can do the at-home measurements (like checking signs and symptoms) on your own.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter course of combined radiation therapy and chemotherapy (using drugs called paclitaxel and carboplatin) to treat esophageal cancer with the goal of curing it. The faster treatment schedule may help patients finish therapy sooner while still being effective.
This trial tests if taking metformin (a diabetes pill) before standard chemoradiation can make esophageal cancer respond better. You take metformin for 2 weeks before starting standard treatment, and doctors will check your tumor with two endoscopies to see how it changes.
This trial tests a new approach for patients with a specific type of esophageal cancer that can be surgically removed. You would first receive a combination of an immunotherapy drug (adebrelimab) with chemotherapy and radiation, and then instead of immediate surgery, your doctor would monitor you closely to see if surgery is still needed. This may help some patients avoid surgery while keeping the cancer under control.
This trial tests a personalized approach using MRI to guide chemotherapy and radiation, combined with immunotherapy, for advanced esophageal cancer that cannot be removed by surgery or has spread to nearby lymph nodes. It aims to improve treatment effectiveness while managing side effects.
This observational study follows people with esophageal cancer to see how their quality of life changes after chemoradiation. It does not change your treatment, but it may help doctors better understand what to expect during and after therapy.
This study tests a new, more precise type of radiation therapy for esophageal cancer that adjusts the treatment in real time using a special CT scan. It aims to deliver a stronger dose to the tumor while sparing healthy tissue, which could improve outcomes.
Hear when a new Locally Advanced Oesophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.